Eric Bjerkholt

Eric Hands Claude Bjerkholt was the founder of Kenady LLC, founded in 1999, where the titles held included President, Chief Executive & Financial Officer from 1999 to 2002.
Current jobs include Independent Director at Cerus Corp.
since 2018, Director at Aimmune Therapeutics UK Ltd. since 2018, Independent Director at Surrozen, Inc. since 2023, Independent Director at Metagenomi Therapeutics, Inc. starting in 2025, and Chief Financial Officer at Mirum Pharmaceuticals, Inc. since 2023.
Former jobs include Independent Director at StemCells, Inc. from 2011 to 2016, Director at Round Table Pizza, Inc., Independent Director at Ambrx, Inc., Director at Corium LLC (Massachusetts) from 2015 to 2018, Director at Atara Biotherapeutics, Inc., Independent Director at Graybug Vision, Inc. from 2020 to 2025, Director at Structure Therapeutics, Inc., Independent Director at CalciMedica, Inc. from 2023 to 2025, Chief Financial Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc. from 2002 to 2004, CFO, Secretary & EVP-Corporate Development at Sunesis Pharmaceuticals, Inc. from 2012 to 2017, Vice President at J.P.
Morgan & Co., Inc. (Delaware) from 1990 to 1997, Chief Financial Officer at Aimmune Therapeutics, Inc. from 2017 to 2020, and Chief Financial Officer at Chinook Therapeutics, Inc. from 2020 to 2023.
Education includes undergraduate studies at the University of Oslo and an MBA from Harvard Business School.